17 The metabolites with fold change ≥1.5 or ≤0.67 and p < 0.05 in t ‐test were considered nominally significant, and the metabolites with false discovery rate (FDR) < 0.05 were considered statistically significant.
← all excerpts
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma.
1
—
—